Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Amneal Pharmaceuticals Q3 Adj. EPS $0.17 Beats $0.14 Estimate, Sales $784.513M Beat $772.310M Estimate

Author: Benzinga Newsdesk | October 30, 2025 05:00am
Amneal Pharmaceuticals (NASDAQ:AMRX) reported quarterly earnings of $0.17 per share which beat the analyst consensus estimate of $0.14 by 23.19 percent. This is a 6.25 percent increase over earnings of $0.16 per share from the same period last year. The company reported quarterly sales of $784.513 million which beat the analyst consensus estimate of $772.310 million by 1.58 percent. This is a 11.68 percent increase over sales of $702.468 million the same period last year.

Posted In: AMRX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist